Generate Investment Management LTD Regeneron Pharmaceuticals, Inc. Transaction History
Generate Investment Management LTD
- $1.8 Trillion
- Q2 2025
A detailed history of Generate Investment Management LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Generate Investment Management LTD holds 12,000 shares of REGN stock, worth $6.76 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
12,000Holding current value
$6.76 Million% of portfolio
0.35%Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,449Shares Held
84.9MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.3 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.7 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.25 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...